For Investors

Release Details

ReWalk Robotics to Present at the H.C. WAINWRIGHT BioConnect Virtual Conference

January 6, 2022

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Jan. 06, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Ori Gon, Chief Financial Officer will present at H.C.WAINWRIGHT BioConnect virtual conference taking place January 10-13, 2022. The fireside chat will be available on demand as of 07:00 AM EST, January 10, 2022 throughout the conference using the following link -

https://journey.ct.events/view/ba68ac34-7e83-42d3-9d2a-c7dc63ff6e50

The fireside chat will also be available on the investor section of the Company’s website at www.rewalk.com.

For additional information and to register, please visit:

https://hcwevents.com/bioconnect/

About ReWalk Robotics Ltd.

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.  ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.

ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.

Contact:
Ori Gon
Chief Financial Officer 
ReWalk Robotics Ltd.
T: +972-4-9590123 
E: investorrelations@rewalk.com


Primary Logo

Source: ReWalk Robotics Ltd.